BOK Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-9,053
Closed -$1.41M 959
2020
Q4
$1.41M Sell
9,053
-6,134
-40% -$788K 0.03% 439
2020
Q3
$1.74M Buy
15,187
+7,630
+101% +$823K 0.04% 349
2020
Q2
$848K Buy
+7,557
New +$802K 0.02% 499
2019
Q3
Sell
-2,037
Closed -$266K 957
2019
Q2
$266K Buy
+2,037
New +$263K 0.01% 799
2019
Q1
Sell
-4,630
Closed -$450K 942
2018
Q4
$450K Buy
4,630
+536
+13% +$63.4K 0.01% 645
2018
Q3
$569K Sell
4,094
-2,157
-35% -$271K 0.01% 647
2018
Q2
$776K Buy
6,251
+3,861
+162% +$451K 0.02% 543
2018
Q1
$266K Sell
2,390
-524
-18% -$62.6K 0.01% 804
2017
Q4
$349K Sell
2,914
-1,542
-35% -$188K 0.01% 758
2017
Q3
$626K Buy
4,456
+540
+14% +$73.4K 0.02% 605
2017
Q2
$476K Sell
3,916
-2,320
-37% -$270K 0.02% 644
2017
Q1
$756K Sell
6,236
-655
-10% -$84.4K 0.02% 550
2016
Q4
$843K Sell
6,891
-95
-1% -$11.6K 0.03% 504
2016
Q3
$856K Buy
6,986
+439
+7% +$56.5K 0.03% 507
2016
Q2
$764K Buy
6,547
+861
+15% +$122K 0.03% 498
2016
Q1
$791K Sell
5,686
-22,181
-80% -$3.26M 0.03% 479
2015
Q4
$5.32M Sell
27,867
-12,058
-30% -$2.11M 0.19% 128
2015
Q3
$6.24M Sell
39,925
-2,591
-6% -$473K 0.24% 96
2015
Q2
$7.69M Sell
42,516
-23,579
-36% -$4.07M 0.26% 90
2015
Q1
$11.5M Buy
66,095
+1,861
+3% +$337K 0.39% 58
2014
Q4
$11.9M Buy
64,234
+10,015
+18% +$1.86M 0.41% 54
2014
Q3
$8.99M Buy
54,219
+32,430
+149% +$5.33M 0.3% 73
2014
Q2
$3.4M Sell
21,789
-2,762
-11% -$436K 0.11% 207
2014
Q1
$3.73M Sell
24,551
-1,376
-5% -$219K 0.12% 186
2013
Q4
$3.45M Sell
25,927
-3,260
-11% -$391K 0.12% 199
2013
Q3
$3.39M Sell
29,187
-4,880
-14% -$535K 0.12% 181
2013
Q2
$3.14M Buy
+34,067
New +$3.28M 0.12% 179

Other funds holding ALXN